The benefits of ascorbate to protect healthy cells in the prevention and treatment of oncological diseases
- PMID: 34907706
- DOI: 10.32725/jab.2020.003
The benefits of ascorbate to protect healthy cells in the prevention and treatment of oncological diseases
Abstract
Health status is determined by the balance of oxidants and antioxidants which protects healthy cells against the threat of internal and external risk factors. Antioxidants such as ascorbate (vitamin C, ascorbic acid) are of fundamental importance in this respect. Ascorbate neutralizes potential damage caused by cellular oxidative stress which may be the greatest risk of damage to healthy tissue. Cellular oxidative stress is mediated by external factors (e.g. psychological stress, physical exertion, drugs, various diseases, environmental pollution, preservatives, smoking, and alcohol) and internal factors (products of cellular metabolism including reactive oxygen species). When the products of oxidative stress are not sufficiently neutralized, healthy cells are at risk for both mitochondrial and DNA damage. In the short term, cell function may deteriorate, while an increased production of proinflammatory cytokines over time may lead to the development of chronic inflammatory changes and diseases, including cancer. Although pharmaceutical research continues to bring effective chemotherapeutic agents to the market, a limiting factor is often the normal tissue and organ toxicity of these substances, which leads to oxidative stress on healthy tissue. There is increasing interest and imperative to protect healthy tissues from the negative effects of radio-chemotherapeutic treatment. The action of ascorbate against the development of oxidative stress may justify its use not only in the prevention of carcinogenesis, but as a part of supportive or complementary therapy during treatment. Ascorbate (particularly when administered parentally at high doses) may have antioxidant effects that work to protect healthy cells and improve patient tolerability to some toxic radio-chemotherapy regimens. Additionally, ascorbate has demonstrated an immunomodulatory effect by supporting mechanisms essential to anti-tumor immunity. Intravenous administration of gram doses of vitamin C produce high plasma levels immediately, but the levels drop rapidly. Following oral vitamin C administration, plasma levels increase slowly to relatively low values, and then gradually decay. With an oral liposomal formulation, significantly higher levels are attainable than with standard oral formulations. Therefore, oral administration of liposomal vitamin C appears to be an optimal adjunct to intravenous administration. In this review, the basic mechanisms and clinical benefits of ascorbate as an antioxidant that may be useful as complementary therapy to chemotherapeutic regimens will be discussed.
Keywords: Ascorbic acid; Cancer; Complementary therapy; Intravenous vitamin C; Liposomal vitamin C; Oxidative stress; Vitamin C.
Conflict of interest statement
The authors report no conflicts of interest in this work.
Similar articles
-
Final report of the safety assessment of L-Ascorbic Acid, Calcium Ascorbate, Magnesium Ascorbate, Magnesium Ascorbyl Phosphate, Sodium Ascorbate, and Sodium Ascorbyl Phosphate as used in cosmetics.Int J Toxicol. 2005;24 Suppl 2:51-111. doi: 10.1080/10915810590953851. Int J Toxicol. 2005. PMID: 16154915 Review.
-
Use of ascorbate-rich dialysate to attenuate oxidative stress in maintenance hemodialysis patients.Ren Fail. 2005;27(2):213-9. Ren Fail. 2005. PMID: 15807188
-
Vitamin C fails to protect amino acids and lipids from oxidation during acute inflammation.Free Radic Biol Med. 2006 May 1;40(9):1494-501. doi: 10.1016/j.freeradbiomed.2005.12.013. Epub 2006 Jan 6. Free Radic Biol Med. 2006. PMID: 16632110
-
The Use of High-Dose Intravenous L-Ascorbate in Pain Therapy: Current Evidence from the Literature.Pain Ther. 2024 Aug;13(4):767-790. doi: 10.1007/s40122-024-00622-5. Epub 2024 Jun 12. Pain Ther. 2024. PMID: 38864974 Free PMC article. Review.
-
Initial biological evaluations of 18F-KS1, a novel ascorbate derivative to image oxidative stress in cancer.EJNMMI Res. 2019 May 17;9(1):43. doi: 10.1186/s13550-019-0513-x. EJNMMI Res. 2019. PMID: 31101996 Free PMC article.
Cited by
-
Comparative Analysis of the Pharmacological Activity of Bis(3,5-di-Tert-Butyl-4-Hydroxyphenylthiolate)Dimethylol in Different Modes of Administration on a Mouse Model of Melanoma B16 Tumor Growth.Bull Exp Biol Med. 2022 Sep;173(5):620-622. doi: 10.1007/s10517-022-05599-9. Epub 2022 Oct 10. Bull Exp Biol Med. 2022. PMID: 36210416
References
-
- Bahlis NJ, McCafferty-Grad J, Jordan-McMurry I, Neil J, Reis I, Kharfan-Dabaja M, et al. (2002). Feasibility and correlates of arsenic trioxide combined with ascorbic acid-mediated depletion of intracellular glutathione for the treatment of relapsed/refractory multiple myeloma. Clin Cancer Res 8: 3658-3668.
-
- Chen Q, Espey MG, Krishna MC, Mitchell JB, Corpe CP, Buettner GR, et al. (2005). Pharmacologic ascorbic acid concentrations selectively kill cancer cells: Action as a pro-drug to deliver hydrogen peroxide to tissues. Proc Natl Acad Sci USA 102: 13604-13609. DOI: 10.1073/pnas.0506390102. - PubMed - DOI
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources